We are live on ! Find out more
KCM

Kingdon Capital Management Portfolio holdings

AUM $976M
1-Year Est. Return 66.76%
This Fund
S&P 500
This Quarter Est. Return
-2.29%
1 Year Est. Return
+66.76%
3 Year Est. Return
+217.15%
5 Year Est. Return
+352.97%
10 Year Est. Return
+2,412.55%
AUM
$959M
AUM Growth
+$89.9M
Cap. Flow
-$12.9M
Cap. Flow %
-1.34%
Top 10 Hldgs %
50.75%
Holding
107
New
30
Increased
18
Reduced
14
Closed
25

Sector Composition

Rank Sector Weight
1 Miscellaneous 42.79%
2 Healthcare 20.79%
3 Industrials 8.56%
4 Consumer Discretionary 7.01%
5 Materials 6.46%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
QQQ icon
1
PUT
Invesco QQQ Trust
QQQ
$489B
$132M 13.79%
365,000
+176,800
+94% +$62.8M
SPY icon
2
PUT
State Street SPDR S&P 500 ETF Trust
SPY
$825B
$94.8M 9.88%
+210,000
New +$93.5M
IWM icon
3
PUT
iShares Russell 2000 ETF
IWM
$80.8B
$40M 4.17%
195,000
+108,000
+124% +$22M
XOP icon
4
State Street SPDR S&P Oil & Gas Exploration & Production ETF
XOP
$3.78B
$38.9M 4.05%
+289,100
New +$33.3M
AMZN icon
5
Amazon
AMZN
$2.87T
$36.7M 3.82%
225,000
+99,260
+79% +$15.3M
META icon
6
Meta Platforms (Facebook)
META
$1.47T
$34.2M 3.56%
153,605
AA icon
7
Alcoa
AA
$13.3B
$33.1M 3.45%
+368,200
New +$26.7M
TECK icon
8
Teck Resources
TECK
$34B
$28.3M 2.95%
699,850
+340,000
+94% +$12.2M
URI icon
9
United Rentals
URI
$64.1B
$24.6M 2.57%
69,305
+24,188
+54% +$7.9M
RAPT
10
DELISTED
RAPT Therapeutics
RAPT
$23.9M 2.49%
136,040
-7,500
-5% -$1.42M
BHVN
11
CALL
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
$23.7M 2.47%
200,000
APG icon
12
APi Group
APG
$17.2B
$22M 2.29%
1,567,692
+37,500
+2% +$550K
TNDM icon
13
Tandem Diabetes Care
TNDM
$1.49B
$20M 2.09%
172,400
+22,400
+15% +$2.62M
CCK icon
14
Crown Holdings
CCK
$12.9B
$19.5M 2.03%
+155,665
New +$18.4M
REGN icon
15
PUT
Regeneron Pharmaceuticals
REGN
$81.8B
$17.5M 1.82%
+25,000
New +$15.8M
ISRG icon
16
Intuitive Surgical
ISRG
$132B
$16.4M 1.7%
+54,200
New +$15.8M
BHVN
17
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
$16.2M 1.68%
136,306
-164,067
-55% -$20.5M
TVRD
18
Tvardi Therapeutics
TVRD
$24.3M
$14.4M 1.5%
32,861
+8,333
+34% +$3.42M
CRL icon
19
Charles River Laboratories
CRL
$13.9B
$14.3M 1.49%
+50,200
New +$15.5M
AZEK
20
DELISTED
The AZEK Co
AZEK
$12.9M 1.34%
+518,000
New +$16.3M
WSC icon
21
WillScot Mobile Mini Holdings
WSC
$3.79B
$12.8M 1.33%
326,029
+69,500
+27% +$2.61M
PANW icon
22
Palo Alto Networks
PANW
$303B
$12M 1.25%
115,500
-117,900
-51% -$10.6M
TNDM icon
23
CALL
Tandem Diabetes Care
TNDM
$1.49B
$11.6M 1.21%
+100,000
New +$11.7M
AMN icon
24
PUT
AMN Healthcare
AMN
$1.34B
$10.4M 1.09%
+100,000
New +$10.4M
GH icon
25
Guardant Health
GH
$21.7B
$9.66M 1.01%
+145,800
New +$9.98M

Similar funds

Kingdon Capital Management's Q1 2022 Portfolio in Review

As of Q1 2022, Kingdon Capital Management held 107 positions worth $959M, up 10% from $870M the previous quarter. Its ten largest holdings account for 51% of the portfolio.

Kingdon Capital Management's Q1 2022 filing shows 30 new, 18 increased, 14 reduced and 25 closed positions. Its largest new stake was State Street SPDR S&P Oil & Gas Exploration & Production ETF: 289,100 shares worth $38.9M. The largest sale was RenaissanceRe, an estimated $29.6M.

By sector, the portfolio is most concentrated in Miscellaneous at 43% of assets, up from 23% a quarter earlier, followed by Healthcare and Industrials.

  • Kingdon Capital Management's largest Q1 2022 buy was State Street SPDR S&P Oil & Gas Exploration & Production ETF: 289,100 shares worth $38.9M.
  • Kingdon Capital Management added most to Amazon in Q1 2022, an estimated $15.3M increase.
  • Kingdon Capital Management's biggest Q1 2022 reduction was Biohaven Pharmaceutical Holding Company Ltd., cutting an estimated $20.5M.
  • Kingdon Capital Management fully exited RenaissanceRe in Q1 2022, selling an estimated $29.6M.
  • Kingdon Capital Management's ten largest holdings make up 51% of its $959M portfolio in Q1 2022.
  • Kingdon Capital Management opened 30 new positions and closed 25 in Q1 2022.
  • Kingdon Capital Management's portfolio value rose 10% quarter-over-quarter to $959M.

Based on Kingdon Capital Management's 13F filing for Q1 2022, filed 16 May 2022.